Oral Thin Films Market Size, Share, Industry Trends and Forecast to 2030

Oral Thin Films Market Size & CAGR in 2021

The global oral thin films market is expected to reach a value of USD 4.5 billion in 2021, with a Compound Annual Growth Rate (CAGR) of 6.2% from 2021 to 2028. This growth is driven by the increasing demand for innovative drug delivery systems and the rising prevalence of chronic diseases.

COVID-19 Impact on the Oral Thin Films Market

The COVID-19 pandemic has had a mixed impact on the oral thin films market. On one hand, the increased focus on healthcare and the need for convenient drug delivery systems have boosted the market growth. On the other hand, disruptions in the supply chain and healthcare services have posed challenges for market players.

Oral Thin Films Dynamics

The oral thin films market is driven by factors such as the growing geriatric population, increasing prevalence of chronic diseases, advancements in drug delivery technologies, and the rising demand for patient-friendly dosing options. Market players are focusing on developing innovative formulations and expanding their product portfolios to gain a competitive edge.

Segments and Related Analysis

The oral thin films market is segmented based on type, disease indication, distribution channel, and region. By type, the market is categorized into sublingual films, buccal films, and fast-dissolving films. The disease indications include opioid dependence, nausea & vomiting, schizophrenia, migraine, and others. The distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies.

By Region Analysis

In terms of region, North America dominates the oral thin films market, followed by Europe, Asia Pacific, Latin America, and Middle East & Africa. The presence of key market players, technological advancements, and high healthcare spending contribute to the growth of the market in these regions.

Key Market Players and Competitive Landscape

Some of the key players in the oral thin films market include ZIM Laboratories, Pfizer Inc., Indivior PLC, APR Applied Pharma Research S.A., and Solvay. These companies are focusing on product innovation, strategic partnerships, and acquisitions to strengthen their market position.

Recent Happenings in the Oral Thin Films Market

- In October 2021, ZIM Laboratories launched a new sublingual thin film for the treatment of acute migraine attacks.

- In January 2022, Pfizer Inc. announced the acquisition of a leading oral thin films manufacturing company to expand its product portfolio.

- In March 2022, Solvay introduced a fast-dissolving oral thin film for the treatment of opioid dependence, catering to the growing demand for innovative drug delivery systems.

- In May 2022, APR Applied Pharma Research S.A. collaborated with a research institution to develop a novel buccal film for the management of schizophrenia, showcasing their commitment to addressing unmet medical needs.